MynxGrip vascular closure device versus manual compression for hemostasis of percutaneous transfemoral venous access closure: Results from a prospective multicenter randomized study.

MedStar author(s):
Citation: Cardiovascular Revascularization Medicine. 19(4):418-422, 2018 06.PMID: 29656937Institution: MedStar Heart & Vascular InstituteonForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Catheterization, Peripheral | *Femoral Vein | *Hemorrhage/pc [Prevention & Control] | *Hemostatic Techniques/is [Instrumentation] | *Vascular Closure Devices | Aged | Aged, 80 and over | Catheterization, Peripheral/ae [Adverse Effects] | Equipment Design | Female | Femoral Vein/dg [Diagnostic Imaging] | Hemorrhage/di [Diagnosis] | Hemorrhage/et [Etiology] | Hemostasis | Hemostatic Techniques/ae [Adverse Effects] | Humans | Male | Middle Aged | Pressure | Prospective Studies | Punctures | Time Factors | Treatment OutcomeYear: 2018Local holdings: Available in print through MWHC library: 2002 - presentISSN:
  • 1878-0938
Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: CONCLUSIONS: The MynxGrip extravascular sealant is safe and effective for femoral venous access site closure.Copyright (c) 2018 Elsevier Inc. All rights reserved.METHODS AND MATERIALS: This is a multicenter, randomized, prospective study of 208 patients who were slated to undergo diagnostic/interventional procedures via femoral venous access. Patients were randomized 1:1 to receive venous hemostasis via MynxGrip (n=104) or manual compression (n=104) utilizing 5, 6, and 7 Fr sheaths. Bilateral calf and thigh circumferences were measured serially. Patients were followed up through hospital discharge. There were no differences in the baseline characteristics between the two groups.PURPOSE: Evaluate the safety of MynxGrip for common femoral vein closure.RESULTS: There was no difference between the groups for venous thrombosis, (0%, p=1). Overall, there was no significant change in access site calf (-0.18+/-1.38cm, p=0.18) or thigh diameter (0.33+/-2.86, p=0.81). In both groups, none of the patients had major or minor vascular complications, access site infection, nerve injury, or access site bleeding requiring transfusion. The pre- to post-procedure hemoglobin drop was -0.51+/-1.1 vs. -0.64+/-1.3g/dL, p=0.59 in the manual compression group and MynxGrip group, respectively. Time to hemostasis, was significantly lower in the MynxGrip group compared to the manual compression group with 0.12+/-0.89 vs. 7.6+/-5.7min, respectively (p<0.001).All authors: Baker NC, Ben-Dor I, Buchanan KD, Craig P, Gai J, Okubagzi PG, Pichard AD, Pokharel S, Rogers T, Satler LF, Torguson R, Waksman RFiscal year: FY2018Digital Object Identifier: Date added to catalog: 2018-05-08
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 29656937 Available 29656937

Available in print through MWHC library: 2002 - present

CONCLUSIONS: The MynxGrip extravascular sealant is safe and effective for femoral venous access site closure.

Copyright (c) 2018 Elsevier Inc. All rights reserved.

METHODS AND MATERIALS: This is a multicenter, randomized, prospective study of 208 patients who were slated to undergo diagnostic/interventional procedures via femoral venous access. Patients were randomized 1:1 to receive venous hemostasis via MynxGrip (n=104) or manual compression (n=104) utilizing 5, 6, and 7 Fr sheaths. Bilateral calf and thigh circumferences were measured serially. Patients were followed up through hospital discharge. There were no differences in the baseline characteristics between the two groups.

PURPOSE: Evaluate the safety of MynxGrip for common femoral vein closure.

RESULTS: There was no difference between the groups for venous thrombosis, (0%, p=1). Overall, there was no significant change in access site calf (-0.18+/-1.38cm, p=0.18) or thigh diameter (0.33+/-2.86, p=0.81). In both groups, none of the patients had major or minor vascular complications, access site infection, nerve injury, or access site bleeding requiring transfusion. The pre- to post-procedure hemoglobin drop was -0.51+/-1.1 vs. -0.64+/-1.3g/dL, p=0.59 in the manual compression group and MynxGrip group, respectively. Time to hemostasis, was significantly lower in the MynxGrip group compared to the manual compression group with 0.12+/-0.89 vs. 7.6+/-5.7min, respectively (p<0.001).

English

Powered by Koha